Mesoblast Limited MESO

momenttrading

NASDAQ:MESO

AlenCiken

Single Dose of Rexlemestrocel-L Provides Substantial and Durable Reduction in Heart Attacks, Strokes and Cardiac Death in Patients With Chronic Heart Failure results from the landmark DREAM-HF randomized controlled Phase 3 trial in 537 treated patients with chronic heart failure with reduced left ventricular ejection fraction (HFrEF) who received rexlemestrocel-L...

AlTorress

I found this pattern at tickeron website with the following data: STATUS = Confirmed CURRENT CONFIDENCE = 71% TARGET (EXIT) PRICE = 11.21 USD BREAKOUT (ENTRY) PRICE = 11.94 USD DISTANCE TO TARGET PRICE = 6.57% EMERGED ON = Oct 12, 08:00 AM (EDT) CONFIRMED ON = Oct 12, 11:59 AM (EDT) WITH CONFIDENCE LEVEL = 85% The Descending Triangle pattern has a horizontal...

danchobraylon

short and long opportunity

harleylucatero2

This stock is approaching a weekly area of demand. Inside the Weekly area of demand, there is a Daily are of demand that you can go long at. use proper risk management if taking this trade. i recommend 1%. If you guys have any financial instruments you guys want me to look at, let me know I'm more then happy to analysis

Hodgo Premium

Awesome when a chart reflects reality. Big trial, big hopes = DANGER. Could buy the break or short the break depending on which way it goes and your mindset.

traderh Pro

Entry 12.00 Cut 13.00 TP 11.30

Hodgo Premium

The phase 3 trial has begun and will take however long it takes with any positive interim news likely to be announced, on balance this offers great risk reward here. My first target is the close from weekt. Then we'll reevaluate.

Hodgo Premium

$MSB after a BGU in the Aussie trading hours, this thing is getting some interest in the US pre market. And for some reason US futures have gone green...

jfisher7

MESO is sitting right under the 200 dma. If MESO can break above and close above the 200 dma then the look for a run to $8.00.

TomLombardozzi

Wait for RSI to drop below 40 then buy